Almirall, ES0157097017

Almirall stock heads into the open after a small loss on BME

Published on 09/09/2026 at 04:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 7, 2026, Almirall stock finished at EUR 10.40 on Bolsa de Madrid, down 0.19 percent, while trading near two-year lows and lagging broader European benchmarks. Today, investors watch sector and market signals ahead of the open.

Dermatologe untersucht Patientenrücken mit Dermatoskop vor Barcelona-Skyline
Almirall S.A. (ES0157097017) zeigt Dermatologie-Praxis mit Hautuntersuchung und unbeschrifteten Cremetuben in Barcelona, Illustration mit AI erstellt.

Almirall stock closed at EUR 10.40 on Bolsa de Madrid on September 7, 2026, slipping 0.19 percent for the day according to market data.MarketScreener That close left the shares near their recent two-year lows and notably below average analyst targets, underscoring continued pressure on the name.

September 7, 2026 in numbers

Almirall SA (ISIN ES0157097017) recorded a last close of EUR 10.40 on its primary listing in Madrid on September 7, 2026, compared with an average analyst target around EUR 14.30, highlighting a gap of roughly EUR 3.90 between the market price and prevailing target levels.MarketScreener Market data show the move amounted to a modest 0.19 percent daily decline, extending a year to date loss of about 19.00 percent as of that session.MarketScreener The share price stood close to levels last seen in summer 2022, indicating that investors have yet to re rate the stock despite reported revenue growth in the first half of 2026.MarketScreener

Today’s focus for September 9, 2026

Today, Almirall enters the session without a fresh company specific release early in the morning of September 9, 2026, so trading is likely to take its cues from broader moves in European equities and healthcare names. Recent market wraps point to cautious sentiment in European shares after an oil price rally, suggesting that overall risk appetite remains fragile.The Business Times For Almirall, the valuation gap versus analyst targets and the proximity to two year lows continue to frame investor expectations ahead of upcoming quarterly updates, even though no specific earnings date within the next few days is highlighted in public calendars.

Disclaimer...

en | ES0157097017 | ALMIRALL | boerse | 70072136 | bgmi